Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Pharma
Asia
Drug Delivery
Executives
Clinical Data
Vaccines
Special Reports
Trending
COVID-19
Cell & Gene Therapy
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Drug Delivery
Pharma
FDA snubs AbbVie's blockbuster-to-be Parkinson's drug
Analysts have projected ABBV-951’s peak sales will reach $1 billion, but one team of analysts sees the potential for it to reach $2 billion or more.
Angus Liu
Mar 22, 2023 11:50am
BMS plots interstellar manufacturing move aboard ISS
Mar 17, 2023 4:00pm
GSK's Cabenuva matches Gilead's Biktarvy in head-to-head study
Feb 22, 2023 11:00am
Revive, PharmaTher team up to develop MDMA microneedle patch
Feb 7, 2023 10:40am
Eisai starts clock ticking on filing for subq Alzheimer's drug
Feb 7, 2023 9:05am
Orexo seeks approval of nasal high-dose opioid rescue medicine
Feb 7, 2023 8:40am
